NSEGeneral Updates1d ago · 17 Nov 2026, 06:18 pm

General Updates

Mangalam Organics Limited · MANORG

✦ AI SummaryResults

Mangalam Organics Limited has informed the Exchange about an Investor Presentation for the quarter ended September 2026, under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact8/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Mangalam Organics Limited has informed the Exchange about Investor Presentation for the quarter ended September, 2026

Attachments (1)

📄

MANORG_17112026181839_IPSEPMOL26sign.pdf

pdf

Download →
View document text
Registered Office / Factory : Village Kumbhivali, Savroli-Kharpada Road, Khalapur-410 202, Dist. Raigad (Maharashtra) Tel. 02192 - 276140 Date: November 17, 2026 BSE Limited The National Stock Exchange of India Limited Listing & Compliance Department Listing & Compliance Department Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1 Block G, Dalal Street, Fort Bandra Kurla Complex, Mumbai – 400001. Bandra (E), Mumbai – 400051 Scrip: 514418 Symbol: MANORG Dear Sir/Madam, Sub: Investor Presentation for Second Quarter and Half Year ended September 30, 2026 under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) Pursuant to Regulation 30 of the Listing Regulations, we hereby enclose a copy of Investor Presentation for Second Quarter and Half Year ended September 30, 2026. This Investor Presentation may also be accessed on the website of the Company at www.mangalamorganics.com. Request you to kindly take the same on record. Thanking you, Yours faithfully, For Mangalam Organics Limited Charmi Shah Company Secretary & Compliance Officer Encl: As above An ISO 9001/14001/45001 2018 Certified Company SAFE HARBOR This presentation and the accompanying slides (the “Presentation”), which have been prepared by Mangalam Organics Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third-party statements and projections. Our Product Portfolio – B2B TERPENE SYNTHETIC RESINS Revenue break-up of Mangalam Organics Limited Our Business Segments B2B- Terpene B2B- Synthetic B2C – Retail Resin Operations •Camphor: Religious use, healthcare products, •Terpene Phenolic •Campure - hygiene products Resin- Adhesives, Homecare and Tyres, Rubbers, Personal Care •Dipentene: Paints, Chewing Gum, Product based on cleaning and degreasing camphor agents •Alkyl Phenolic Resin- Printing Ink •Mangalam - •Sodium Acetate: Textile Camphor tablets for and dyes industry, pious uses, Private •Resin Esters Leather tanning labelling Initiatives •lsobornyl Acetate, •lsoborneol Our Product Portfolio – B2C ( MANGALAM ) CCoonnssuummeerr--FFooccuusseedd BBuussiinneessss Mangalam - Camphor tablets for pious uses Private Labelling Initiatives Our Product Portfolio – B2C ( CAMPURE ) Consumer-Focused Business CamPure - Homecare and personal care products based on Camphor Our Business Model A robust and integrated model that creates value at every step Cost Chemistry B2C Retailing Competitive Advantage Capabilities Expertise Edge High Product Strong R&D and Strong consumer High Product quality, innovation deep chemistry connect and retail quality, innovation and operational expertise enable us capabilities help us and operational efficiencies give us a to develop high reach customers efficiencies give us sustainable edge in quality and effectively and build a sustainable edge a competitive innovative products trusted brands in a competitive market market FY26 Consolidated Financial Performance Revenues (Rs. Crs) EBITDA (Rs. Crs) PAT (Rs. Crs) +17.46 % + 49.91 % +103.04% 622.57 530.00 87.82 25.38 58.58 12.50 FY26 FY25 FY26 FY25 FY26 FY25 EBITDA Margin (%) PAT Margin (%) • Revenue growth of 17.46 % in FY26 vs FY25. +306 + 172 bps • Decrease in input costs lead to profitability for the year. 14.11% 4.08% 11.05% 2.36% • Company continues its efforts on improving efficiencies and margins going forward. FY26 FY25 FY26 FY25 10 QOQ FY27 Q2 Consolidated Financial Performance Revenues (Rs. Crs) EBITDA (Rs. Crs) PAT (Rs. Crs) 78.02 % 7596% 281.46 158.10 21.55 0.28 3.02 3.02 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 EBITDA Margin (%) PAT Margin (%) -88 bps +748 bps Revenue Growth of 78.02 % in Q2 FY27 as compared to Q2 FY26. Continued focus on enhancing operational efficiencies andstrengtheningmarginsgoing forward. 7.66% 0.18% 1.14% 2.02% Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 11 Q1 FY27 Consolidated Profit & Loss Statement Q2FY27 Q2 FY26 Y-o-Y (%) Q1FY27 Q-O-Q FY26 FY25 Y-o-Y (%) Particulars (Rs. Crs) Revenue from Operations 281.46 158.10 78.03 179.09 57.16 622.57 530.01 17.46 Cost of Materials Consumed 199.45 99.67 122.89 365.34 312.47 Purchase of stock in trade 0.09 3.94 0.04 7.87 6.86 Changes in Inventories of finished goods, work in -1.15 -1.03 -19.97 -45.18 -45.85 progress and stock-in trade Gross Profit 83.07 55.52 49.62 76.13 9.12 294.54 256.53 14.82 GP % 29.5 35.1 42.5 47.3 48.4 Employee Benefits Expense 14.13 12.08 13.55 49.92 41.54 Other Expenses 47.39 43.16 40.37 156.80 156.41 EBITDA 21.55 0.28 7596 22.21 -2.97 87.82 58.58 49.91 EBITDA % 7.66 0.18 12.40 14.11 11.05 Other Income 0.05 20.54 0.07 4.75 0.33 Depreciation and Amortisation Expense 7.51 6.13 6.16 27.58 20.82 EBIT 14.09 14.69 -4.08 16.12 -12.59 64.99 38.09 70.62 Finance Costs 9.09 6.99 7.42 28.19 21.47 PBT 5 7.7 -35.06 8.7 -42.53 36.8 16.61 121.55 Less: Exceptional Loss 0 3.5 - 0 -3.5 - PBT after Exceptional Loss 5 4.18 - 8.7 33.3 - Less: Tax Expense 1.8 0.98 1.43 7.92 4.11 Profit for the year 3.2 3.2 0.00 7.27 -55.98 25.38 12.5 103.04 PAT % 1.14 2.02 4.06 4.08 2.36 EPS 3.74 3.73 8.49 29.64 14.6 Profit & Loss Statement (Audited) as on March 2026 Particulars (Rs. Crs) FY26 FY25 FY24 FY23 Revenue from Operations 622.57 530.01 493.52 492.5 Cost of Materials Consumed 365.34 312.47 258.93 409.4 Purchase of stock in trade 7.87 6.86 6.37 6.5 Changes in Inventories of finished goods, work in progress and stock-in trade -45.18 -45.85 37.37 -72.7 Gross Profit 294.54 256.53 190.85 149.3 GP % 47.3 48.40 38.67 30.31 Employee Benefits Expense 49.92 41.54 39.07 34.7 Other Expenses 156.80 156.4 113.11 117.4 EBITDA 87.82 58.59 38.67 -2.8 EBITDA % 14.11 11.05 7.84 -0.57 Other In [Showing first 8,000 characters — download PDF for full document]